FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

N Nakaigawa

Research Profile

Chemicals & Drugs

Anatomy

3T3 Cells

Disorders

Genes & Molecular Sequences

Living Beings

Mouse

Physiology

Procedures

Sequence Alignment

Phenomena

Phosphorylation

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Alla Danilkovitch-Miagkova; Alexei Miagkov; A Skeel; N Nakaigawa; Berton Zbar; Edward J Leonard
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
M Miller; Krzysztof Ginalski; Bogdan Lesyng; N Nakaigawa; L Schmidt; Berton Zbar
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies.
N Nakaigawa; Gregor Weirich; L Schmidt; Berton Zbar
Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of N Nakaigawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2001: Alla Danilkovitch-Miagkova; Alexei Miagkov; A Skeel; N Nakaigawa; Berton Zbar; Edward J Leonard
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
Molecular and cellular biology 2001;21(17):5857-68.
2001: M Miller; Krzysztof Ginalski; Bogdan Lesyng; N Nakaigawa; L Schmidt; Berton Zbar
Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto-oncogene: modeling studies.
Proteins 2001;44(1):32-43.
2000: N Nakaigawa; Gregor Weirich; L Schmidt; Berton Zbar
Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src.
Oncogene 2000;19(26):2996-3002.
1999: L Schmidt; K Junker; N Nakaigawa; T Kinjerski; Gregor Weirich; M Miller; Irina A Lubensky; H P Neumann; Hiltrud Brauch; J Decker; Cathy D Vocke; James A Brown; R Jenkins; S Richard; U Bergerheim; B Gerrard; M Dean; W Marston Linehan; Berton Zbar
Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
Oncogene 1999;18(14):2343-50.
1997: M Jeffers; L Schmidt; N Nakaigawa; Craig Webb; Gregor Weirich; T Kishida; Berton Zbar; George Vande Woude
Activating mutations for the met tyrosine kinase receptor in human cancer.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(21):11445-50.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.